close search

HOMER2 study

Hepatocellular carcinoma (HCC) incidence is increasing in Australia and is associated with high mortality. However, there is limited data on the epidemiology of liver cancer in Australia, including the impact.

  1. To describe trends in HCC incidence and aetiology over time in Victoria
  2. To describe trends in mortality rates for HCC over time
  3. To determine factors associated with survival, including health services utilizationa dn enrolment in liver cancer surveillance
  4. To describe the impact of marginalization on HCC stage at diagnosis, treatment uptake and clinical outcomes

2012-2025

Prospective cohort study with data linkage

Understanding the rapidly changing trends in epidemiology of HCC in Victoria is essential to design effective prevention programs. Treatment approaches to HCC are changing rapidly.

This study will provide evidence for factors that are associated with improved survival outcomes to inform cost-effectiveness modelling.

Associate Professor Jessica Howell

Contact Associate Professor Jessica Howell for more information about this project. 

EMAIL

Funding
Partners

  • NHMRC Program grant
  • Ramsay Program grant
  • Gilead Sciences
  • Eisai Australia

Partners +
Collaborators

  • Melbourne Liver Group
  • St Vincent’s Hospital Melbourne
  • Western Health
  • Northern Health
  • Eastern Health
  • Melbourne Health
  • Alfred Health
  • Austin Health
  • Monash Health

Project
Team

Meet the project team. Together, we are translating research into better health, for all.